Our patients have numerous choices regarding advanced technology and eye care. Advances range from how patients check in for an appointment to what tools a surgeon uses to dissect tissue. They all have their benefits, and all come at a cost.
We often perform cataract surgery with near vision correction, using monovision or presbyopia-correcting intraocular lenses (IOLs). These folks are typically happy despite having mild residual refractive error. Something magically happens between that patient getting glasses that she “just cannot wear, at all” and getting cataract surgery. Let’s follow that patient’s path.
We have all been there, wrapping up the exam of a complex patient with many ocular diseases wishing there was more time to break down each diagnosis and educate the patient a bit more.
We ODs have an inherent advantage our patients do not—we know what’s coming.
T’was the night before Christmas, and all through the towns, not an optometrist was stirring—not even an online retailer promising glasses at low cost.
The ocular surface encompasses not only the cornea, but the all-important supporting conjunctiva that is divided into the bulbar, limbal, palpebral, forneaceal, and marginal zones.
Eyecare practitioners who deal with patients in the perioperative period are well aware of the need for topical therapy. In most cases, a combination of a steroid, a nonsteroidal anti-inflammatory drug (NSAID), and an antibiotic will be used for a few days before the day of surgery and then for a period afterward.
Modern ophthalmic cataract surgery now employs sophisticated techniques to improve outcomes and patient satisfaction. This includes surgical systems providing better control, lasers to perform manual techniques, and intraoperative evaluation to evaluate surgical endpoints before the patient leaves the operating room (OR).
Years ago, I realized that a cataract is anomaly of the ocular system that should be eradicated at its earliest stages. Frankly, if you were in a relationship that was not going well and was destined to keep getting worse, would you stay?
A study recently published in JAMA Ophthalmology found that long-term daily supplementation with selenium and/or vitamin E did not have a beneficial effect on cataract risk in men.